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The transgenic SAD mouse: A model of human sickle cell
glomerulopathy
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The transgenic SAD mouse: A model of human sickle cell glomerulopa-
thy. The transgenic SAD mouse which expresses a modified sickle
hemoglobin, Hb SAD, displays in vivo hemoglobin polymerization and
eiythrocyte sickling. In the present study functional and morphological
renal analyses were performed in SAD mice in order to compare the renal
pathology of SAD mice with the human disease. The SAD mice display
renal hemosiderosis, microvascular occlusions, vascular thrombosis, cor-
tical infarcts and papillary necrosis. In the medulla, hemoglobin polymers
could be observed with infrequent erythrocyte sickling, which may explain
the absence of significant renal concentration defect, whereas in humans,
the difference in the vascularization network leads to more extensive
sickling. Most animals develop glomerular hypertrophy and mesangial
sclerosis which increases in frequency and severity with age. The glomer-
ular damage is associated with functional defects, including increased
blood urea nitrogen levels and non-selective proteinuria. The glomerular
lesions of SAD mice strikingly mimick sickle cell glomeruloscierosis, the
most severe renal complication of sickle cell disease in humans. In
summary, the SAD mouse is a valuable model of the thrombotic and
glomeruloscierotic complications of human sickle cell glomerulopathy and
can serve for pathophysiologic studies, and, eventually, for prevention and
therapy investigation.
Since the initial report of patients with sickle cell disease (SCD)
by Herrick in 1910 [1], the renal involvement has been well
documented [2, 3]. A wide spectrum of functional and morpho-
logic abnormalities affect the kidneys of patients with sickle cell
disorders. The majority of patients with SCD suffer functional
abnormalities, notably a concentrating defect, partial distal tubu-
lar acidosis and impaired potassium excretion [3]. While these
mild and mainly functional abnormalities are regarded as the
classic renal manifestations of SCD, the disease can be accompa-
nied by more severe clinical abnormalities such as proteinuria,
nephrotic syndrome and end-stage renal disease [2, 4, 5]. Al-
though nephrotic-range proteinuria is relatively rare (incidence
4%) [5], 15 to 50% of patients with SCD develop mild to
moderate proteinuria [6—8]. All of the glomerular diseases with
proteinuria in SCD patients share the features of mesangial
sclerosis and/or hypercellularity [2, 5, 9—12]. In severe cases, the
term 'membranoproliferative glomerulonephritis' has been used
but recently the descriptor 'glomerulosclerosis' has been proposed
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since the lesions appear much more sclerotic than proliferative
[13]. Other less frequent renal complications of SCD include
hematuria, papillary necrosis and pyelonephritis [2].
The prognosis of nephrotic syndrome in patients with SCD is
poor, leading to chronic renal failure in two-thirds of the patients
and death within two years in half of the patients [5]. Overall,
end-stage renal disease accounts for approximately 20% of deaths
in adult SCD [2, 14—17], and as the life expectancy of patients with
SCD increases with improved medical care, renal disease is likely
to emerge as a major health problem in SCD.
Some mechanisms of the renal pathophysiology of SCD are
explainable. The vasoocclusive complications and the minor func-
tional abnormalities such as the concentrating defect and the
tubular acidosis can be attributed to erythrocyte sickling, favored
by the acidity, hyperosmolarity and low oxygen content affecting
the medullary vasa recta [3]. However, the pathogenesis of SCD
glomerulopathy, the most serious renal complication, is poorly
understood. A major hindrance to understanding this pathogen-
esis has been the lack of an animal model.
Transgenic mouse models of SCD can contribute significantly
to the unraveling of the pathogenesis of the renal manifestations
of this disease. The availability of large numbers of animals allows
us to study the evolution of the disease through sequential
functional and morphological analysis. Furthermore, with an
animal model, it is possible to clearly define the role of the genetic
component, environmental conditions (such as, oxygenation) or
iatrogenic factors (for example, transfusion-related iron overload)
on SCD renal pathogenesis.
We have developed a transgenic mouse model which exhibits a
sickle cell syndrome [18]. The transgenic SAD mouse was gener-
ated by cointroduction of the human a2-globin gene and a novel
-globin gene (/3SAD) and expresses a modified hemoglobin 5, Hb
SAD [18]. The Hb SAD has a similar polymer structure and
polymerization process than Hb S but with a lower solubility [18].
Transgenic SAD mice showed in vitro and in vivo sickling of the
erythrocytes with ultrastructural evidence of hemoglobin polymer-
ization, microvascular occlusions and thrombosis and systemic
hemosiderosis in the absence of anemia [18] (Note added in proof).
Hematologic and histopathologic analysis demonstrated that the
phenotype displayed by transgenic SAD mice strongly resembles
human SCD [18]. In the present report, we have performed a
detailed morphologic and functional analysis of the kidneys of
transgenic SAD mice in order to evaluate the SAD mouse as a model
of human sickle cell glomerulopathy.
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Table 1. Histologic findings in SAD mice
Animal
Age







1 19 0 0 0 8 2
2 21 0 0 0 5 0
3 24 0 0 0 6 1
4 33 0 0 0 6 0
5 36 0 0 0 3 2
6 36 0 0 0 3 12
7 38 0 0 0 16 10
8 38 0 0 0 2 2
9 38 1 1 0 5 0 penile infarct
10 40 0 0 0 8 19 thrombosis
11 42 1 2 1 6 90 fibrosis medulla
12 42 0 0 0 3 17
13 42 0 0 0 7 0
14 42 1 1 1 6 37 priapism, thrombosis,
infarcts
15 56 1 1 0 2 0 papillary necrosis,
infarcts
16 62 1 0 0 5 90
17 64 0 2 0 6 2
18 66 0 2 0 9 0
19 70 0 0 0 11 54
20 72 0 1 0 12 27
21 75 1 1 0 34 22
22 75 1 2 0 8 71
23 75 0 2 2 15 0
24 76 0 1 1 6 90
25 82 0 1 0 16 1
26 85 0 0 0 10 87
27 86 0 2 1 5 85
28 88 0 1 0 20 8
29 88 0 2 0 10 85
30 88 0 0 0 5 0
31 98 0 2 1 5 0 papillary fibrosis
Abbreviations are: Scler foc/seg, % of glomeruli affected by focal
segmental sclerosis; scler glob, % of glomeruli affected by global sclerosis.
a Congestion, iron: 0, none-mild; 1, moderate; 2, severe
Methods
Renal histopathologic studies were performed on SAD mice of
both sexes (N = 31, 22 males, 9 females), ranging in age from 19
to 98 weeks (mean age 58 weeks; Table 1). Seven animals (4
males, 3 females, mean age 56 weeks) were autopsied immediately
after spontaneous death or sacrificed when they appeared termi-
nally ill. Of these animals, one showed priapism and another a
hemorrhagic infarct of the penis. The other 24 transgenic SAD
mice were sacrificed in relatively healthy condition. Mice positive
for the SAD transgene were identified by hemoglobin electro-
phoresis on cellulose acetate [18]. Negative littermates (N = 10)
served as controls and ranged in age from 43 to 99 weeks (mean
age 62 weeks).
The kidneys were dissected immediately after death (spontane-
ous or by cervical dislocation). Half of each kidney was fixed in
10% PBS-buffered formalin and processed for light microscopy.
Paraffin-embedded tissue was sectioned at 4 rm thickness and
stained with hematoxylin eosin. Special stains included periodic
acid-Schiff (PAS), PAS-methenamine silver, MSB (Martius, Scar-
let, Blue) and Prussian-blue. Glomeruli from randomly selected
microscope fields were evaluated for the type and degree of
sclerosis, hypertrophy, mesangial and endocapillary hyperplasia
(>10 nuclei/capillary tuft) and the presence of synechiae or
crescents (100 glomeruli per kidney, 200 per animal). In addition,
the sections were studied for the presence of infarcts, iron
deposits and other pathologic alterations documented in human
sickle cell glomerulopathy.
The glomerular profile area was determined by measuring the
glomerular tuft using direct planimetry (MOP 3, Carl Zeiss),
whereby the magnification was estimated with a stage micrometer.
For morphometrical analysis, the renal cortex was arbitrarily
divided in the outer one-third and the inner two-thirds. In the
outer fields, a minimum of 50 randomly selected glomeruli was
measured in each kidney (minimum 100 glomeruli per animal),
and in the inner fields, the profile area was determined for at least
25 juxtamedullary glomeruli per kidney (minimum 50 glomeruli
per animal).
Direct immunofluorescence studies were performed on renal
biopsies which were previously snap-frozen in liquid nitrogen and
stored at —90"C. Four-micron-thick cryostat sections were fixed in
absolute acetone at room temperature for 10 minutes and then
washed twice in PBS, pH 7.2, for 10 minutes each. The sections
were then incubated with fluorescein-5-isothiocyanate (FITC)-
conjugated goat IgG fraction to mouse IgG F(ab')2 and to mouse
complement C3 (Cappel, Organon Teknika Corp., Durham,
North Carolina, USA), followed by two washes in PBS for 10
minutes each. The sections were examined with a Zeiss micro-
scope equipped with epifluorescence illumination. Different con-
trols were included: (1) incubation with goat IgG fraction to
human IgG and C3 (Cappel); (2) omission of primary antibody;
and (3) replacement of primary antibody by diluted normal goat
serum.
Ultrastructural analyses of the kidneys from SAD and control
mice were undertaken. Biopsies of the renal cortex were fixed in
2.5% buffered glutaraldehyde and post-fixed in 1% osmium
tetroxide. Two to five biopsies were taken per animal at the time
of sacrifice. The tissues were dehydrated in a graded series of
ethanol solutions and embedded in Epon 812. Thin sections were
stained with uranyl acetate and lead citrate and examined with a
JEOL 1200-EX transmission electron microscope at an acceler-
ating voltage of 60 kV.
The renal function of transgenic SAD mice and negative
littermates was analyzed. The mean age of SAD mice was 56
weeks (range 9 to 112 weeks) and that of control mice 52 weeks
(range 9 to 92 weeks). Functional studies were limited to male
mice to avoid gender-related variability in urinary protein excre-
tion 1191. All animals were allowed free access to food and water.
To evaluate glomerular function, abnormal protein leakage was
assessed by the urinary protein/creatinine (UP/C) ratio from
untimed urine samples [20], a quantitative method previously
used in mouse models [21]. Aliquots of urine containing 50 sg of
total protein were qualitatively analyzed using 10% SDS-PAGE
and Coomassie blue staining as described [22]. Urine osmolality
was determined after overnight deprivation of water. Blood urea
nitrogen (BUN) and creatinine levels were determined on serum
obtained from peripheral blood of the tail vein.
Statistical analysis
Unpaired two-sample Student's f-test and the Mann-Whitney U
test were used for statistical analysis; P < 0.05 was considered
significant. When appropriate, values are expressed as mean
standard deviation.
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Fig. 1. Abundant iron deposits in tubular
epithelium of SAD kidney. Iron is absent in the
glomerular tufts although occasionally staining
is observed in Bowman's capsule (Prussian blue
stain, X 200).
Fig. 2. Kidney of SAD mouse showing mesangial
glomerulosclerosis with endocapillaiy
hypercellularity (PAS stain, X 400).
Results
Histologic studies
The transgenic animals displayed a spectrum of vasoocckisive
complications (Table 1). Mild to moderate congestion of the
medullary and cortical capillaries and venules was observed in
50% of the SAD mice. In the medulla, microvascular congestion
was often associated with vascular distension and packing of the
vessels with deformed erythrocytes, indicative of microvascular
occlusion. Unequivocal erythrocyte sickling was apparent in two
animals (animals 11 and 31). Thrombosis of cortical arterioles,
cortical infarcts, medullary and papillary fibrosis and necrosis of
the papilla were observed with variable frequency (3 to 10% of the
animals). Stainable iron deposits were seen in six mice (19%) (Fig.
1). All these animals showed iron deposits prominently in the
tubular epithelium, while half of these animals (animals 11, 14 and
27) also displayed small amounts of iron in the glomerular
Bowman's capsule and cortical interstitium. Fragmented erythro-
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Table 2. Mean glomerular profile area in relation to age, sclerosis and
congestion
Mice
Outer cortex Inner cortex
Inner/outerpm2
SAD 396.1 85.9 701.1 151.2 1.79 0.25
(N = 26)
SAD > 50 weeks 412.1 80.9 748.1 125.6 1.84 0.21
(N = 16)
SAD > 50% 404.7 63.0 821.3 109.7 1.97 0.30
sclerosis
(N =7)
SAD congestion 432.7 63.3 816.9 134.7 1.90 0.23(N=8)
Control 248.1 27.1 445.5 58.9 1.79 0.12
(N =7)
The glomeruli of SAD mice showed varying degrees of sclero-
sis. The sclerotic process was predominantly mesangial and
ranged from slight accentuation of the mesangial stalk to promi-
nent mesangial widening with peripheral displacement of the
capillaries (Fig. 2). PAS-positive deposits suggestive of hyalinosis
lesions, were observed in all cases with moderate to severe
glomerulosclerosis. Duplication of the basement membrane was
observed rarely. Crescents and synechiae were prominent in 10%
of mice (animals 11, 21 and 26), always in association with severe
glomerulosclerosis. Fibrin deposits identified by MSB staining
were present in the sclerotic glomeruli of renal sections from one
of three SAD mice analyzed.
Glomerulosclerosis was graded as mild (less than 25% of
glomeruli involved by focal segmental or global sclerosis), mod-
erate (25% to 50%) and severe (over 50%). According to these
criteria, severe glomerulosclerosis was observed in 29% of the
SAD mice (9 of 31), whereas 45% of the animals (14 of 31)
displayed at least moderate glomerulosclerosis. All of the control
animals showed less than 10% glomerulosclerosis. The mean age
of mice exhibiting severe glomerulosclerosis (73.2 14.3 weeks)
was significantly higher than that of mice showing mild glomeru-
losclerosis (49.8 25.5 weeks, P C 0.01). Further, five of seven
terminally ill mice showed moderate to severe degrees of glomer-
ulosclerosis.
Seven SAD mice had obvious enlargement of the glomerular
tuft with narrowing of Bowman's space, owing to hyperplasia of
the mesangial and endocapillasy cells in combination with capil-
lary congestion. The juxtamedullary glomeruli displayed the great-
est degree of hypertrophy.
Three of seven animals that had died spontaneously displayed
vasoocclusive complications such as priapism and penile infarc-
tions, papillary necrosis and cortical infarcts, which may have
contributed to their death. Interestingly, all remaining four ani-
mals that had died showed severe degrees of glomerulosclerosis,
with involvement of over 80% of glomeruli in three. These results
suggested that death in SAD mice could also be caused by chronic
renal failure.
Morphometty
Quantitative morphometrical analysis showed that the mean
glomerular area in SAD mice was significantly larger than that in
control mice for both inner and outer glomeruli (P C 0,01; Table
2). The mean glomerular area of the outer glomeruli of SAD mice
was relatively constant and appeared more or less unaffected by
Table 3. Renal function studies
SAD Control












2167.0 324.4' (18)1819.4 479.9k'
mOsm/kg (15) (8)
Values are expressed as mean SD. Numbers in parenthesis represent
the number of animals examined. BUN is blood urea nitrogen.
a P c 0.05
bNot statistically significantF < 0.01
age, glomerulosclerosis or congestion. In contrast, the inner
glomerular profile area showed wider variation and was larger in
SAD mice with severe glomerulosclerosis and with congestion of
the renal microvasculature. In 88% of SAD mice the mean profile
area of the inner glomeruli was larger than the maximum value
observed in control mice (513.9 jxm2). In all animals, the profile
area of inner glomeruli was approximately twice as large as that of
outer glomeruli. In the SAD mice, the ratio inner/outer glomer-
ular profile area tended to be higher in animals with severe
degrees of sclerosis and congestion (Table 2).
Immunofluorescence
A large number of SAD mice developed glomerulosclerosis in
association with expansion of the mesangium as occasionally
observed in human SCD. Among various hypothetical pathophys-
iologic mechanisms in human SCD, the glomerulopathy could be
associated with an autologous immune reaction [121. The nature
of the glomerulosclerotic defect in SAD mice was therefore
further analyzed by immunohistochemistry and electron micros-
copy. In SAD mice with severe glomerulosclerosis (animal 21 and
22), the kidneys demonstrated large mesangial deposits of both
IgU and complement component C3 (Fig. 3 A & B). IgO and C3
deposits were present in each mesangial region of all glomeruli. In
addition, some glomeruli contained weak linear deposits of IgG
along the glomerular basement membranes. In animals with very
mild glomerulosclerosis (animals 7 and 8), faint mesangial depos-
its of IgO without C3 staining were observed. In two non-
transgenic control mice, irregular punctate deposits of IgG were
seen in the mesangial areas of some glomeruli in the absence of
C3 deposits. Incubation with anti-human IgU resulted in very
weak mesangial staining, similar to that observed in non-SAD
control mice, and staining for human C3 was negative. No
glomerular staining was observed when the primary antibody was
omitted and replaced with PBS or diluted serum.
Electron microscopy
Electron microscopic analyses were performed on SAD kidneys
to evaluate the sclerotic process and investigate for the presence
of dense deposits. Ultrastructurally, the glomeruli of SAD mice
showed varying degrees of mesangial cell proliferation with
expansion and sclerosis of the mesangial matrix (Fig. 4). In mice
with severe mesangial sclerosis (animals 21 and 22), the process
often involved the entire glomerulus with virtual obliteration of
the capillary lumina. The basement membrane showed mild
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Fig. 3. A. Direct immunofluorescence stain of
SAD kidney showing a granular mesangial
staining pattern for IgG. B. The same kidney
stained for complement component C3
demonstrating an identical staining pattern
(x 850).
variation in thickness and occasional splitting due to interposition
of mesangial matrix, The foot processes were focally fused over
areas of sclerosis. Pronounced sclerosis of the mesangium was
invariably associated with immune-complex-like dense deposits
(Fig. 4). The red blood cells of SAD mice showed Hb SAD
polymers, in the form of randomly oriented bundles of paracrys-
talline structures of varying length and number (Fig. 5 and inset).
Free or lysosome-bound electron-dense bodies, ranging from 50
to 800 nm in diameter and compatible with ferritin and iron-
protein complexes, were observed in the apical region of the
tubular epithelium. The kidneys of control mice had no abnor-
malities at the ultrastructural level.
Renal function studies
Proteinuria, as evaluated by the mean UP/C ratio on untimed
urine samples [20] was significantly increased in SAD mice
compared with control animals (P < 0.01; Table 3). The urinary
protein was qualitatively analyzed by SDS-PAGE (Fig. 6). Urine
samples from SAD and control mice contained defined bands of
low molecular weight (± 17,000 daltons) proteins, representing
the major urinary proteins (MUP). Mice older than 15 months
had non-selective proteinuria. This was demonstrated by the
similar distribution of proteins in normal mouse serum and in
urine samples of SAD mice aged from 21 to 26 months. A 66,000
dalton band was found to increase in density with age and most
likely represents albumin. The mean BUN level was significantly
higher in SAD mice than in control animals (P < 0.05). No
significant difference could be demonstrated between the mean
serum creatinine level and urine osmolality of SAD and control
mice (0.05 <P < 0.1).
Discussion
The renal pathology of transgenic SAD mice shows many
striking similarities to the human sickle cell nephropathy. SAD
.J
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Fig. 4. Mesangial sclerosis and mesangial cell
hypeiplasia of SAD glomerulus. Immune-
complex-like dense deposits suggestive of
hyalinosis lesions are present in the mesangial
areas (arrow) and there is occasional mesangial
interposition of the basement membrane
(arrowhead). Erythrocytes in the glomerular
capillaries display hemoglobin polymers and
aberrant shapes (Uranyl-acetate and lead-
citrate, X 2,400).
mice display renal hemosiderosis, microvascular occlusions, vas-
cular thrombosis, cortical infarcts and papillary necrosis. Further-
more, both glomerular hypertrophy and mesangial glomeruloscie-
rosis were present in half of the animals and increased in
frequency and severity with age. Also associated with these
glomerular damages were functional defects: increased blood
urea nitrogen levels, non-selective proteinuria and, progression to
renal failure.
Some of the renal alterations in SAD mice can be attributed to
the sickle hemoglobinopathy. Renal iron deposition, a component
of systemic hemosiderosis in SAD mice [18], is the result of
chronic hemolysis of altered SAD erythrocytes. Interestingly, iron
deposits were almost exclusively present in the apical side of the
tubular epithelium, identical to the localization in human SCD [5,
9, 10, 12, 23]. Similarly, the vasoocclusive complications of vascu-
lar thrombosis, cortical infarctions and papillary necrosis in SAD
kidneys are most likely the result of in vivo polymerization of
hemoglobin SAD and consequent sickling of SAD erythrocytes
[18]. Unlike humans [3], only a minority of SAD mice displayed
unequivocal sickling in the medullary vasculature, although sick-
ling can be readily observed in many other organs (Note added in
proof). This discrepancy can probably be related to the peculiar
anatomy of the medullary microvasculature in mice compared to
human. Whereas the medullary vasa recta in human have a small
diameter, the vessels of mice are formed by the fusion of multiple
small vessels into large bundles [24] which may impede the
deformation of SAD erythrocytes and protect against vasoocclu-
sions. The absence of a concentrating defect can probably be
ascribed to this anatomic feature in SAD mice as well as in mice
expressing Hb S under atmospheric oxygenation [25].
Whereas the results of renal hemosiderosis and thrombotic
complications can be explained on the basis of microvascular
sickling and hemolysis, the pathogenesis of the glomerular dam-
age in mice with a sickle hemoglobinopathy is more obscure.
Glomerular hypertrophy, a prevalent finding in children and
young adults with SCD [10, 11, 23, 26], was observed in the
majority of the transgenic mice. As in humans [27, 28], the
glomerular hypertrophy of SAD mice may result from increased
glomerular filtration rates as suggested by the preferential hyper-
trophy of juxtamedullary glomeruli.
Prominent mesangial glomerulosclerosis associated with non-
selective proteinuria was observed in approximately half of the
Paepe and Trudel: Transgenic model of sickle cell glomerulopathy 1343
Fig. 5. Eiythrocytes within capillaries of the renal cortex showing cytoplasmic polymers (X 10,200). The hemoglobin polymers are arranged in randomly
oriented fascicles; the arrow indicate the area depicted in the inset (X 42,000) (uranyl-acetate and lead-citrate).
SAD mice, and its incidence was found to increase with age.
Therefore, the development of proteinuria and glomerulosclero-
sis, not observed in age-matched control mice, appears to be
specifically associated with the expression of Hb SAD in the
transgenic mice.
A study of the glomerulopathy of SAD mice may provide
insight on the etiology of chronic renal failure, a major cause of
death in SCD. In humans, various hypotheses have been postu-
lated to explain the sickle glomerulopathy, none of which seem to
be entirely satisfactory. Based on animal experiments, the sickle
glomerulopathy has been attributed to iron overload [5, 9, 23].
However, it seems unlikely that iron plays a role in the pathogen-
esis of the glomeruloscierosis in SAD mice or in humans [10, 12],
because of the relative paucity of iron deposits within the glomer-
ular mesangium of both species. Alternatively, the progressive
glomerular damage of patients with SCD has been related to
hyperfiltration which is characteristic of early SCD [3, 11, 27, 28].
Such a role of hyperfiltration in glomerular injuries is supported
by studies on the remnant kidney model [29]. In this respect, it is
interesting to note that in our study a correlation was observed
between the degree of glomerular sclerosis and hypertrophy.
In some patients with SCD, the glomerular damage of patients
with SCD has also been proposed to be the result of an autologous
immune-complex nephritis [2, 12, 30, 31]. In the present study,
severe glomerulosclerosis in SAD mice was uniformly associated
with mesangial electron dense deposits and aggregates containing
IgG and complement factor C3. The predominantly granular
mesangial pattern and the invariable colocalization of IgG and C3
to the same site suggest that mesangial deposition of immune
complexes can indeed contribute to the glomerulosclerosis of
SAD mice.
The nature of the antigens triggering the immune reaction
remains speculative. Several antigens have been proposed to be
implicated in the autologous immune-complex nephritis of pa-
tients with SCD [30]. Some of these cannot be operant in SAD
mice, such as transfusion-related blood antigens; others such as
exposure to microbial antigens are unlikely because of the ab-
sence of histologic or clinical evidence of infection. Alternatively,
the human immune-complex nephritis has been attributed to
tubular antigens released secondary to ischemic tubular necrosis
[30]. Since the vast majority of SAD mice with severe glomerulo-
sclerosis and immune-complex deposits displayed no visible evi-
dence of tubular damage, tubular antigens most likely do not
SI
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Fig. 6. SDS-PAGE of urine from SAD and C57BL/6J control mice. Abbreviations are: M, molecular weight marker (daltons); 5, mouse serum. Numbers
above lanes indicate mouse age in months. Low molecular weight bands of 17,000 daltons (lower arrow) representing the major urinary proteins
(MUP) are abundant in all animals. SAD mice display non-selective protein spillage, as indicated by the appearance of molecular weight bands of
66,000 dalton, probably representing albumin (higher arrow), which increase in density with age.
underlie the immune-complex nephritis in these transgenic ani-
mals. Hence, the pathogenetic mechanism resulting in autologous
immune-complex deposits could be investigated using the trans-
genic SAD model.
In summary, these experiments show that transgenic SAD mice
develop many functional and morphologic aspects of human sickle
cell nephropathy, including a range of vascular complications,
tubular iron deposits, glomerular hypertrophy and sclerosis, and
proteinuria. The SAD mouse can therefore serve as a model of
these aspects of human sickle cell glomerulopathy. The resem-
blance between the glomerular lesions in SAD mice and in
humans with SCD is striking. In view of the high morbidity and
mortality associated with the glomerular damage in SCD, the
SAD mice as a model may provide insight into the pathophysiol-
ogy of the sickle cell glomerulopathy and possible approaches to
therapeutic intervention.
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